505(b)2 and Drug Approval Pathways
From WSPA Ambulatory Care Academy Podcast by WA State Pharmacy Assoc
February 3, 2025 · 27 min
About this episode
Darell Connor discusses the 505(b)2 drug approval pathways and their impact on ambulatory care pharmacy.
Join us for another episode of the Ambulatory Care Academy Podcast where we have an insightful discussion with Darell Connor, AmCA student representative, Doctor of Pharmacy Candidate 2025 from Creighton University and Pharmacy Corporate Project Manager with the American Oncology Network. In this AmCA Podcast, Darell discusses the 505(b)2 drug approval pathways and its impacts. Drug approval has evolved, and how patients may eventually get medications has expanded beyond "FDA drug approval". Listen in as we converse with Darell and learn how the 505(b)2 pathway will impact ambulatory care pharmacy.
People in this episode
Guest: Darell Connor
Topics covered
- drug approval pathways
- ambulatory care pharmacy
- 505(b)2
- patient access to medications
- pharmacy education
Keywords
- 505(b)2
- drug approval
- ambulatory care
- pharmacy
- FDA
Mentioned in this episode
Organizations: Creighton University, American Oncology Network, FDA
More episodes of WSPA Ambulatory Care Academy Podcast
- Rx Reddit React Podcast · February 20, 2026 · 57 min
- Special Paths to Amb Care: An Interview with Dr. Sara McElroy · June 9, 2025 · 20 min
- Pain and Palliative Care · July 10, 2024 · 1h 13m
- Population Health - Where To Begin and Where We Are Going · January 2, 2024 · 1h 15m
- Community Practice Residency: Tips and Considerations · April 18, 2023 · 32 min
- Learning in the Time of COVID-19 · January 4, 2023 · 1h 15m
Explore listener stats, chart rankings, contacts and more on the WSPA Ambulatory Care Academy Podcast podcast page.